Spots Global Cancer Trial Database for Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)
Official Title: Phase II Study of Nanocurcumin Versus Placebo for Patients Undergoing Radiotherapy for Prostate Cancer
Study ID: NCT02724618
Conditions
Study Description
Brief Summary: There is a growing body of evidence exploring the role of curcumin as a radioprotector against radiation-induced injury in normal tissues as well as a radiosensitizer in tumor cells. The aim of this study is to determine the efficacy of oral nanocurcumin in prostate cancer patients undergoing radiotherapy.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Shohada-e-Tajrish Medical Center, Tehran, , Iran, Islamic Republic of
Contact Details
Name: Abolfazl Razzaghdoust
Affiliation: Shahid Beheshti University of Medical Sciences
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
